The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
10-Mar-10
$576 million
Target:
Camelot Group plc
Acquiror:
Ontario Teachers’ Pensions Plan
Advised the shareholders of Camelot – Cadbury, De La Rue, Fujitsu, Royal Mail and Thales – on the sale of their shareholdings in Camelot, the operator of the UK National Lottery, to Ontario Teachers’ Pensions Plan
08-Jan-10
$134 million
Target:
Minerva plc
Acquiror:
KiFin Limited
Advised Minerva plc, a UK real estate development company, on its successful defence following an unsolicited offer from KiFin Limited, a company that makes investments for the benefit of Mr Nathan Kirsh
09-Nov-09
$327 million
Target:
Enzon Pharmaceuticals, Inc.
Acquiror:
Sigma-Tau Pharmaceuticals
Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company
08-Oct-09
$455 million
Target:
Ladbrokes Plc
Acted as Joint Financial Adviser to Ladbrokes plc, a leading UK based betting and gaming company, on its rights issue
18-Sep-09
$81 million
Target:
UKAEA Limited
Acquiror:
Babcock International Group plc
Advised United Kingdom Atomic Energy Authority Non Departmental Public Body, arm of the UK Government, on the sale of UKAEA Limited, its commercial nuclear decommissioning services business, to Babcock International Group plc
21-May-09
$111 million
Target:
Shanks Group plc
Acted as Financial Adviser and Sponsor to Shanks Group plc, a leading European waste management group, on its rights issue
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
01-Oct-08
$53 million
Target:
Biotage (Biosystems division)
Acquiror:
Qiagen NV
Advised Biotage AB (OMX: BIOT), a global biotechnology company, on its strategic review resulting in the disposal of its Biosystems division which offers systems for genetic analysis mainly for use in clinical research
22-Jan-08
$3.4 billion
Target:
Ventana Medical Systems, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of Ventana Medical Systems, Inc., a US based provider of histopathology diagnostic equipment
26-Nov-07
$11.4 billion
Target:
Kelda Group plc
Acquiror:
Citi Infrastructure Investors, GIC Special Investments, Infracapital Partners and HSBC Bank
Advised Kelda Group plc, a leading provider of water and waste water services in the UK, on a recommended cash offer from a consortium of international infrastructure investors
25-Jun-07
$8.1 billion
Target:
Energy East Corporation
Acquiror:
Iberdrola SA
Advised Energy East Corporation, a super-regional electric and gas utility with nearly 3 million regulated customers in the northeast US, on its sale to Iberdrola SA
04-Jun-07
$2.9 billion
Target:
Slough Estates USA (subsidiary of Slough Estates plc)
Acquiror:
Health Care Property Investors
Provided oversight of the process and an informal second opinion to the senior management of Slough Estates plc
29-Jan-07
$900 million
Target:
Eggborough CTA Bonds
Acquiror:
Ampere plc (a newly formed company)
Advised an ad hoc committee of bondholders representing over 70% of the debt in Eggborough Power Limited, a UK power station, on (a) the formation of a new company for the purpose of acquiring and holding a controlling interest in the Eggborough CTA Bonds and (b) an associated US$600m financing. The Eggborough CTA Bonds include an option to purchase Eggborough power station in March 2010
24-Mar-06
$21.2 billion
Target:
Schering AG
Acquiror:
Bayer AG
Advised Bayer on its public offer for Schering, an international pharmaceuticals group based in Berlin, Germany
24-Feb-06
$860 million
Target:
Aquarion Company
Acquiror:
Macquarie Bank
(a wholly-owned subsidiary of Kelda Group plc) Advised Kelda Group plc on the sale of Aquarion Company, one of the largest investor-owned water utilities in the US
15-Dec-05
$4.5 billion
Target:
Drax Group Limited
Advised bondholders of Drax Group Limited on the refinancing & listing of, and possible offers for, the company. On 15-Dec-05, Drax Group plc was successfully listed on the London Stock Exchange
28-Apr-04
$161 million
Target:
Atlantic Electric and Gas Ltd
Acquiror:
Scottish and Southern Energy plc
Advised Atlantic Electric and Gas, an affiliate of Sempra Energy, on the sale of its assets to Scottish and Southern Energy.
09-Jun-03
$237 million
Target:
Kelda Group plc’s
Acquiror:
Terra Firma Investments
46% stake in Waste Recycling Group plc
Advised Kelda Group plc on the disposal of its 46% stake in Waste Recycling Group plc.
18-Jan-02
$520 million
Target:
Thus plc
Advised THUS plc on its underwritten £275 million open offer, £90 million bank loan and demerger from its parent, ScottishPower
01-Jun-99
$601 million
Target:
Aquarion Company
Acquiror:
Kelda Group plc
Advised Kelda Group (formerly Yorkshire Water) on the all-cash purchase of Aquarion Company, a US water utility group.